PDAC | P value | BTC | P value | ||||
---|---|---|---|---|---|---|---|
αSMA | αSMA | αSMA | αSMA | ||||
positive | negative | positive n = 83 | negative n = 71 | ||||
n = 67 | n = 47 | ||||||
Sex | men | 37 | 21 | 0.26 | 46 | 40 | 0.26 |
women | 30 | 26 | 37 | 31 | |||
Age, median (range) | 68(34–85) | 73(56–83) | 0.06 | 70(43–87) | 68(43–86) | 0.23 | |
T category | pT0–2 | 20 | 9 | 0.19 | 56 | 33 | a0.008 |
pT3–4 | 47 | 38 | 27 | 38 | |||
Lymph node metastasis | absent | 32 | 22 | 0.92 | 64 | 39 | a0.003 |
present | 35 | 25 | 19 | 32 | |||
Distant metastasis | absent | 61 | 45 | 0.31 | 81 | 62 | a0.01 |
present | 6 | 2 | 2 | 9 | |||
Lymphatic invasion | absent | 6 | 10 | 0.06 | 43 | 17 | a0.01 |
present | 61 | 37 | 32 | 32 | |||
Vascular invasion | absent | 38 | 29 | 0.59 | 66 | 37 | 0.06 |
present | 29 | 18 | 9 | 12 | |||
Neural invasion | absent | 10 | 8 | 0.76 | 43 | 15 | a0.001 |
present | 57 | 39 | 28 | 34 | |||
UICC stage | ≦2 | 59 | 44 | 0.31 | 69 | 41 | a < 0.001 |
> 2 | 8 | 3 | 14 | 30 | |||
Serum CEA level | < 5 ng/ml | 38 | 29 | 0.72 | 63 | 56 | 0.62 |
≧5 ng/ml | 27 | 18 | 14 | 10 | |||
Serum CA19–9 level | < 37 U/ml | 19 | 18 | 0.26 | 52 | 28 | a0.008 |
≧37 U/ml | 48 | 29 | 28 | 37 | |||
Serum SPan-1 level | < 30 U/ml | 18 | 20 | 0.09 | |||
≧30 U/ml | 48 | 27 |